KR0131288B1 - Aerosol spray composition for removing fungus using new fungicides - Google Patents

Aerosol spray composition for removing fungus using new fungicides

Info

Publication number
KR0131288B1
KR0131288B1 KR1019930032149A KR930032149A KR0131288B1 KR 0131288 B1 KR0131288 B1 KR 0131288B1 KR 1019930032149 A KR1019930032149 A KR 1019930032149A KR 930032149 A KR930032149 A KR 930032149A KR 0131288 B1 KR0131288 B1 KR 0131288B1
Authority
KR
South Korea
Prior art keywords
aerosol spray
acid
spray composition
serine
amino acid
Prior art date
Application number
KR1019930032149A
Other languages
Korean (ko)
Other versions
KR950016507A (en
Inventor
진기홍
이동탁
박용만
Original Assignee
김정순
제일제당주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김정순, 제일제당주식회사 filed Critical 김정순
Priority to KR1019930032149A priority Critical patent/KR0131288B1/en
Publication of KR950016507A publication Critical patent/KR950016507A/en
Application granted granted Critical
Publication of KR0131288B1 publication Critical patent/KR0131288B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • A01N25/06Aerosols

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Here is provided an aerosol spray composition for eradicating mildew -to remove mildew from its habitat or inhabitable place by convenient spray. An antifungal AF-021A of molecular formula C52H85022N11 and molecular weight 1215, composed of glypeptide antibiotics, includes betahydroxyl asparagine, aspartic acid, serine, glycine, 2,4-diamino butyric acid, betahydroxyl tyrosine, methylene chain compound and gyrase at the ratio of 1:1:2:1:1:1:1:1.

Description

새로운 항진균제를 이용한 곰팡이 제거용 에어로졸 스프레이 조성물Aerosol Spray Compositions for Mold Removal Using New Antifungal Agents

본 발명은 곰팡이가 서식하는 곳, 즉 차량에어콘, 욕실, 습기진 실내벽면, 카펫 등에 분사하여 우수한 곰팡이 제거효과를 주는 새로운 항진균제가 함유된 에어로졸 스프레이 조성물에 관한 것이다.The present invention relates to an aerosol spray composition containing a new antifungal agent by spraying in the mold, that is, the vehicle air conditioner, bathroom, damp indoor wall, carpet, etc. to give excellent mold removal effect.

곰팡이는 일반적으로 알고 있는 비병원성 균뿐만 아니라 인체에 치명적인 균이 주변에 다량 존재하고 있다. 이들 병원성 곰팡이에 의해 야기되는 대표적인 병이 아스퍼길러스 푸미카터스(Aspergillus fumigatus)의 감염에 의해 나타나는 기관지 국균증(麴菌症) 및 곰팡이성 페렴이다.Fungi are not only non-pathogenic bacteria that are generally known, but also a lot of deadly bacteria. Representative diseases caused by these pathogenic fungi are bronchial fungal disease and fungal pneumonia caused by infection with Aspergillus fumigatus.

기관지 국균증 외에 곰팡이에 의해 야기되는 질병으로는 급성 부비강염(副鼻腔炎), 피부병 등이 있다.(USP 제4,950,477호) 기관지 구균증은 일단 감염되어 병증이 나타나면 치료하기가 매우 어렵다. 종래에는 기관지 국균증 치료를 위해 암포테리신-B(Amphotericin-B) 주사 및 수술 등이 치료 수단으로 이용되고 있으나, 암포테리신-B는 통증이 매우 심하여 환자들이 견디기 어려운 단점이 있으며 간, 비장, 신장 등에 다량 잔류한다고 보고 되어 있다.In addition to bronchial fungal disease, fungal diseases include acute sinusitis and skin diseases (USP No. 4,950,477). Bronchococcosis is very difficult to treat once an infection has developed. Conventionally, amphotericin-B (Amphotericin-B) injection and surgery have been used as a therapeutic means for the treatment of bronchial aseptic disease. However, amphotericin-B is very painful and difficult for patients to endure. It is reported that a large amount, such as, elongation.

이러한 곰팡이 감염에 의한 질병은 대부분 생활 주거환경에 기생하는 곰팡이 포자의 흡입으로 유발되며, 이러한 질병의 예방은 주위에 기생하는 곰팡이 균을 제거함으로써 가능해진다. 이러한 곰팡이균들을 제거하기 위한 간편한 방법은 에어로졸 스프레이(Aerosol spray)로 곰팡이균들이 서식하는 곳 또는 서식 잠재성이 있는 곳에 분사하여 생활주변 환경의 곰팡이들을 없애는 것이다.Diseases caused by fungal infections are mostly caused by inhalation of mold spores parasitic in living and living environment, and prevention of such diseases is made possible by removing parasitic fungi around. An easy way to get rid of these fungi is to use aerosol sprays to spray them where they live or where they live, potentially eliminating mold in the surrounding environment.

에어로졸 스프레이형 곰팡이 제거 조성물을 만드는 데는 다음과 같은 요건들이 구비되어야 한다.The following requirements must be met to make an aerosol spray type mold removal composition.

1) 소량의 항진균제로서 큰 항지균 활성이 있어야 한다.1) As a small amount of antifungal agent, it should have great antifungal activity.

2) 피부 및 눈에 강한 자극성이 없어야 한다.2) There should be no strong irritation to skin and eyes.

3) 환경 잔류 활성이 강하여야 한다.3) Environmental residual activity should be strong.

본 발명자들은 이러한 모든 항목을 충족시키는 항진규제 AF-021A를 개발하여 출원한 바 있으며(대한민국 특허출원 제93-22090호), 이 AF-021A는 글리코펩타 이드 안티바이오틱스(Glycopeptide antibiotics)로서 분자량이 1215이고 C52H85O22N11의 분자식으로 표시되며, 베타하이드록시 아스파라진, 아스파르틱산, 세린, 글리신, 2,4-디아미노 부티릭산(DAB), 베타하이드록시 타이로신, 메틸렌 사슬구조 아미노산과 자이로스(Xylose)가 1:1:2:1:1:1:1:1의 비율로 구성되어 있고, 펩티드의 N-말단에서 C-말단 방향으로의 아미노산 결합순서가 세린-베타하이드록시 타이로신-아스파르틱산-세린-글리신-2,4-디아미노부티릭산-베타하이드록시 아스파라진-메틸렌 사슬구조 아미노산의 순서이고, 자일로스가 메틸렌 사슬수조 아미노산에 결합되어 있는 환상구조의 펩티드이다.The present inventors have developed and filed an anti-fungal regulation AF-021A that satisfies all these items (Korean Patent Application No. 93-22090), and this AF-021A is a glycopeptide antibiotics having a molecular weight of 1215 and represented by the molecular formula of C 52 H 85 O 22 N 11 , betahydroxy asparagine, aspartic acid, serine, glycine, 2,4-diamino butyric acid (DAB), betahydroxy tyrosine, methylene chain structure Amino acid and Xylose are composed of 1: 1: 2: 1: 1: 1: 1: 1, and the amino acid binding sequence from the N-terminus to the C-terminus of the peptide is serine-betahydrate. Roxy tyrosine-aspartic acid-serine-glycine-2,4-diaminobutyric acid-betahydroxy asparagine-methylene chain structure Amino acid sequence, and xylose is a cyclic peptide bound to methylene chain tank amino acid .

항진균제 AF-021A에 대한 자세한 내용은 대한민국 특허출원 제93-22090호에 잘 명시되어 있다.The details of the antifungal agent AF-021A are well specified in Korean Patent Application No. 93-22090.

본 발명자들이 개발한 상기의 항진규제 AF-021A는 AF-021A1과 AF-021A22가지가 있으며(이하 021A로 통칭한다.), 미생물 기원으로서 슈도모나스 세파시아(Pseudomonas cepacia) KFCC 10773를 배양하여 생산하였고, 기존의 암포테리신-B, 케토코나졸보다 최소 저지농도(MIC) 값이 우수하며 본 발명에서 사용하고자 하는 용도에 적합한 항진균제임을 알 수 있었다.The above anti-development AF-021A developed by the present inventors has two kinds of AF-021A 1 and AF-021A 2 (hereinafter, collectively referred to as 021A), and cultured Pseudomonas cepacia KFCC 10773 as a microbial origin. It was produced, it was found that the minimum inhibitory concentration (MIC) value is superior to the existing amphotericin-B, ketoconazole and is suitable antifungal agent for use in the present invention.

본 발명에서는 상기의 항진균제 AF-021A를 에탄올 또는 이소프로필 알코올 등의 용매에 용해시켜 에어로졸 스프레이 조성물을 제조하는데, 이때 필요에 따라 스프레이형 조성물에 통상 이용되는 첨가제 등을 사용할 수도 있다.In the present invention, the above antifungal agent AF-021A is dissolved in a solvent such as ethanol or isopropyl alcohol to prepare an aerosol spray composition. In this case, additives commonly used in spray-type compositions may be used, if necessary.

이하 참고예 및 실시예를 통하여 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail with reference to Examples and Examples.

참고예 1.Reference Example 1.

기존에 개발된 항진균제와 AF-021A의 MIC 비교 시험.MIC comparison of antifungal agent and AF-021A.

효모 종류는 우선 액체 배지에 배양하고, 아스퍼길러스(Aspergillus) 같은 곰팡이류는 감자 덱스트로스 한천(Potato Dextrose Agar; Difco사 제품, 이하 PDA)에 도말하여 포자를 형성 시킨 후 포자를 수거하여 시험에 사용하였다. MIC 시험은 희석법이 아닌 한천 평판법(Agar plate method)을 사용하였는데 그 방법은 다음과 같다.Yeast is first cultured in a liquid medium, and molds such as Aspergillus are spread on potato dextrose agar (PDA), and then spores are collected and used for testing. It was. The MIC test used the Agar plate method, not the dilution method.

PDA에 암포테리신-B, 케토코나졸 및 AF-021A를 0, 1, 10, 15, 20, 25 μg/ml되게 넣어 한천평판을 제조하였다. 이 배지에 상기에서 제조한 포자 및 균을 도말하여 균이 자라지 않는 범위를 일차로 정한 다음 다시 그 농도 범위를 좁혀서 각각의 균들이 자라지 못하는 농도를 결정하였다. 그 결과는 다음 표 1에 나타내었다.Agar platelets were prepared by adding 0, 1, 10, 15, 20, 25 μg / ml of amphotericin-B, ketoconazole and AF-021A to PDA. The spores and bacteria prepared above were plated on the medium to determine the range where the bacteria did not grow first, and then the concentration range was narrowed again to determine the concentration at which the respective bacteria did not grow. The results are shown in Table 1 below.

표 1에 나타난 바와 같이 MIC 값에서 AF-021A가 기존의 항진균제보다 더욱 우수함을 알 수 있었고, 따라서 AF-021A를 사용하여 곰팡이 제거제를 만들 경우 기존의 제품보다 적은 농도에서 큰 효과를 낼 수 있을 것을 확인할 수 있었다.As shown in Table 1, it was found that AF-021A was superior to conventional antifungal agents in the MIC value. Therefore, if AF-021A was used to make a mold remover, it could have a greater effect at a lower concentration than conventional products. I could confirm it.

참고예 2. AF-021A의 피부 자극성 시험Reference Example 2. Skin irritation test of AF-021A

기존의 항진균제인 암포테리신-B, 케토코나졸 및 본 발명에 이용되는 AF-021A의 피부에 대한 자극성을 조사하였다. 시험방법으로는 사람피부 첩포 테스트를 사용하였다. 우선 피검자를 여성 및 남성 구분없이 20-30세 사이에서 각각 15명을 선별하여 총 30명을 시험대상으로 하였다.The anti-fungal agents of amphotericin-B, ketoconazole and AF-021A used in the present invention were investigated for irritation to the skin. Human skin patch test was used as a test method. First of all, 15 subjects were selected from 20 to 30 years old regardless of female and male subjects.

각 항진균제를 200μg/ml되게 용해시킨 다음 디스크여지(paper disc : 직경 0.8㎜)에 각 용액을 흡수시키고, 흰 챔버(Finn chamber : Norgesplaster A/S, Norway)에 넣어 피검자의 팔의 하박부에 48시간 부착하여 다음과 같은 기준으로 판정하였다.Dissolve each antifungal agent to 200μg / ml, absorb each solution in paper disc (diameter 0.8mm), and put it in a white chamber (Finn chamber: Norgesplaster A / S, Norway) in the lower part of the arm of the subject. It adhered for time and determined on the following criteria.

[판정 기준][Criteria]

++ : 발적(redness)이 심한 경우 (2점)++: In case of severe redness (2 points)

+ : 발적이 조금 있는 경우 (1점)+: If there is some redness (1 point)

± : 발적이 미약한 경우 (0.5점)±: When redness is weak (0.5 point)

- : 발적이 없는 경우 (0점)-: No redness (0 points)

시험 결과는 다음 표 2에 나타내었다.The test results are shown in Table 2 below.

표 2에 나타난 결과처럼 AF-021A가 다른 기존의 항진균제에 비하여 상대적으로 피부에 자극성이 적으며, 에어로졸 스프레이(aerosol spray) 제조에 적합함을 알 수 있었다.As shown in Table 2, AF-021A was relatively less irritating to the skin than other conventional antifungal agents, and was found to be suitable for aerosol spray production.

참고예 3. AF-021A의 눈 자극성 시험Reference Example 3. Eye irritation test of AF-021A

참고예 2의 피부 자극성 시험에서와 같은 농도(200μg/ml)를 전후로 농도별(100, 150, 200, 250ppm)로 눈자극성에 대한 시험을 실시하였으며, 시험방법으로는 아이텍스 시스템(Eytex(Ropak사) system)에 따라 아이텍스(Eytex) 시약 UMA를 이용하여 실시하였으며, Ropak사에서 제공하는 소프트웨어(Softeware)를 이용하여 최종 판정하였다. 판정기준은 표 3과 같다.Tests on eye irritation were carried out by concentration (100, 150, 200, 250 ppm) before and after the same concentration (200 μg / ml) as in the skin irritation test of Reference Example 2, and the test method was an Eyetex system (Eytex (Ropak). G) system) was performed using the Eytex reagent UMA, and finally determined using the software provided by Ropak (Softeware). Criteria are shown in Table 3.

시험 결과는 표4에 나타난 바와 같이 AF-021A는 220ppm이하에서 최소 자극으로 판정되었고 암포테리신-B 및 케토코나졸은 약간의 자극으로 판정되어 AF-021A가 종래의 항진균제보다 눈에 대한 자극성이 훨씬 적음을 알 수 있다.As shown in Table 4, AF-021A was determined to be the minimum stimulus below 220ppm, and amphotericin-B and ketoconazole were judged to be slight stimulation, so that AF-021A was much less irritating to eyes than conventional antifungal agents. It can be seen.

실시예. AF-021A를 이용한 에어로졸 스프레이의 제조 및 그 성능시험.Example. Preparation of Aerosol Spray Using AF-021A and Its Performance Test.

AF-021A를 이용하여 다음 표 5의 조성에 따라 에어로졸 스프레이를 제조하였다.An aerosol spray was prepared according to the composition of Table 5 using AF-021A.

상기 표 5의 각 단량을 순서대로 첨가하여 잘 녹인 다음 250㎖ 용량의 캔에 넣고 액체 프로판 가스(이하 LPG) 70g을 충전시켜 에어로졸 스프레이를 제조하였다.Each unit of Table 5 was added in order to dissolve well, and then put into a 250 ml can, and filled with 70 g of liquid propane gas (hereinafter referred to as LPG) to prepare an aerosol spray.

또한 같은 조성물을 이소프로필 알코올 대신 에탄올로 녹여서 비교 실험을 행하였다.In addition, a comparative experiment was conducted by dissolving the same composition in ethanol instead of isopropyl alcohol.

우선 0.1% Tween 20용액으로 PDA 배지 상에 있는 아스퍼길러스 포자를 분산시켜 10 cell/㎖되게 희석하였다. 이 포자를 같은 용액으로 세척하고, 증류수로 2번 더 세척하였다. 다시 증류수로 10 cell/㎖되게 희석하고 와트만(whatman) 여과지 2번을 직경 9㎝되게 원형으로 자르고 여기에 증류수를 3㎖ 흡수한 다음 포자용액 1㎖를 다시 고르게 분포시켰다. 이 여과지를 일회용 페트리 디쉬에 부착시키고 조된 에어로졸 스프레이를 1회 분사하여 2주일간 28℃에서 배양하여 포자의 사멸 여부를 조사하였다. 그 결과는 다음 표 6에 나타내었다.First, disperse Aspergillus spores on PDA medium with 0.1% Tween 20 solution. Dilute to cell / ml. The spores were washed with the same solution and washed twice with distilled water. 10 with distilled water again After diluting to cell / ml, Whatman filter paper No. 2 was cut into circles 9 cm in diameter, and 3 ml of distilled water was absorbed therein, and 1 ml of the spore solution was evenly distributed again. The filter paper was attached to a disposable petri dish, and the prepared aerosol spray was sprayed once and incubated at 28 ° C. for 2 weeks to investigate whether or not the spores were killed. The results are shown in Table 6 below.

상기 표 6에 나타난 바와 같이 용매가 이소프로필 알코올과 에탄올일 때 사멸율이 차이가 나며 에탄올에서 99% 이상 살균됨을 알 수 있습니다.As shown in Table 6 above, when the solvent is isopropyl alcohol and ethanol, the mortality rate is different and it can be seen that more than 99% sterilization in ethanol.

참고예 4. AF-021A의 안정성 시험Reference Example 4. Stability Test of AF-021A

AF-021A의 환경에서의 안정성을 위하여 다음 항목을 중점적으로 조사하였다.The following items were focused on the stability of the AF-021A in the environment.

(1) 산성 pH 및 알카리성 pH에서의 AF-021A의 안정성을 조사하기 위하여 0.2M Citrate-Phosphate buffer(pH 3, 5, 7, 9, 10)에 각각 100ppm 되게 AF-021A를 첨가하여 30℃에서 2, 4, 6, 8주 간격으로 항균 활성을 조사하였다. 항균 활성 시험은 실시예의 방법을 이용하였다. 그 결과, 8주후 산성(pH4)에서 80%의 활성을 유지하였고, 알카리성 pH에서는 95%이상의 활성이 잔존하였다.(1) In order to investigate the stability of AF-021A at acidic pH and alkaline pH, AF-021A was added to 0.2M Citrate-Phosphate buffer (pH 3, 5, 7, 9, 10) at 100 ppm, respectively, at 30 ° C. Antimicrobial activity was examined at intervals of 2, 4, 6 and 8 weeks. The antimicrobial activity test used the method of the Example. As a result, after 8 weeks, 80% of the activity was maintained in acid (pH 4), and at least 95% of the activity remained at alkaline pH.

(2) AF-021A의 고온 안정성을 알아보기 위하여 50% 에탄올(pH7)에 100ppm되게 용해시켜 시험한 결과 60℃에서 1일간 보존하여도 항균활성이 그대로 유지되나, 100℃에서 30분간 처리하면 항균활성이 50% 감소되었다.(2) In order to find out the high temperature stability of AF-021A, it was tested by dissolving 100ppm in 50% ethanol (pH7), and the antimicrobial activity was maintained even when stored at 60 ℃ for 1 day. Activity was reduced by 50%.

(3) LPG 가스 충진 상태에서의 시간에 따른 안정성(3) Stability over time in LPG gas filled state

실시예의 조성대로 에어로졸 스프레이를 제조할 경우 캔내의 압력이 약 5-7kgf/㎠이 되는데 이러한 압력하에서의 AF-021A가 얼마나 안정한가를 1개월 간격으로 조사하였다. 항균 활성시험은 실시예의 방법을 이용하였다. 그 결과 압력이7kgf/㎠이하에서 14개월 동안 아무런 항균활성의 감소가 없었다. 상기 결과에서처럼 AF-011A는 고온, 고압, 산성, 알카리성 pH에서 높은 안정성을 유지하였으며, 에어로졸 스프레이에 가장 적합한 항진균제임을 알 수 있었다.When the aerosol spray was prepared according to the composition of the example, the pressure in the can was about 5-7 kgf / cm 2. How stable the AF-021A under such pressure was examined at one month intervals. The antimicrobial activity test used the method of the Example. As a result, there was no decrease in antimicrobial activity for 14 months when the pressure was below 7kgf / ㎠. As described above, AF-011A maintained high stability at high temperature, high pressure, acidic and alkaline pH, and was found to be the best antifungal agent for aerosol spray.

Claims (2)

분자량이 1215이고 C52H85O22N11의 분자식으로 표시되며, 베타하이드록시 아스파라진, 아스파르틱산, 세린, 글리신, 2,4-디아미노 부티릭산, 베타하이드록시 타이로신, 메틸렌 사슬구조 아미노산, 자일로스가 1:1:2:1:1:1:1:1의 비율로 구성되며, 펩티드의 N-말단에서 C-말단 방향으로의 아미노산 결합순서가 세린-베타하이드록시타이로신-아스파르틱산-세린-글리신-2,4디아미노부티릭산-베타하이드록시 아스파라진-메틸렌 사슬구조 아미노산의 순서이고, 자일로스가 메틸렌 사슬구조 아미노산에 결합되어 있는 환상구조의 펩티드인 항진균제 AF-021A가 함유된 곰팡이 제거용 에어로졸 스프레이 조성물.It has a molecular weight of 1215 and is represented by a molecular formula of C 52 H 85 O 22 N 11 , betahydroxy asparagine, aspartic acid, serine, glycine, 2,4-diamino butyric acid, betahydroxy tyrosine, methylene chain amino acid Xylose is composed of 1: 1: 2: 1: 1: 1: 1: 1, and the amino acid binding sequence of the peptide from the N-terminus to the C-terminus is serine-betahydroxytyrosine-aspar. Tic acid-serine-glycine-2,4diaminobutyric acid-betahydroxy asparagine-methylene chain amino acid sequence, containing antifungal agent AF-021A which is a cyclic peptide in which xylose is bound to methylene chain amino acid Aerosol Spray Composition For Removing Mold. 제1항에 있어서, 상기 AF-021A의 농도가 100-200ppm인 것을 특징으로 하는 에어로졸 스프레이 조성물.The aerosol spray composition of claim 1 wherein the concentration of AF-021A is 100-200 ppm.
KR1019930032149A 1993-12-31 1993-12-31 Aerosol spray composition for removing fungus using new fungicides KR0131288B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019930032149A KR0131288B1 (en) 1993-12-31 1993-12-31 Aerosol spray composition for removing fungus using new fungicides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019930032149A KR0131288B1 (en) 1993-12-31 1993-12-31 Aerosol spray composition for removing fungus using new fungicides

Publications (2)

Publication Number Publication Date
KR950016507A KR950016507A (en) 1995-07-20
KR0131288B1 true KR0131288B1 (en) 1998-04-11

Family

ID=19375061

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930032149A KR0131288B1 (en) 1993-12-31 1993-12-31 Aerosol spray composition for removing fungus using new fungicides

Country Status (1)

Country Link
KR (1) KR0131288B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210086795A (en) 2019-12-30 2021-07-09 한국세라믹기술원 Manufacturing method of natural plant extract coated filter having for its own antibacterial

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210086795A (en) 2019-12-30 2021-07-09 한국세라믹기술원 Manufacturing method of natural plant extract coated filter having for its own antibacterial

Also Published As

Publication number Publication date
KR950016507A (en) 1995-07-20

Similar Documents

Publication Publication Date Title
DE69835279T2 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS USING CATIONIC PEPTIDES ALONE OR IN COMBINATION WITH ANTIBIOTICS
US6479532B1 (en) Antifungal compositions
EP0711305B1 (en) Protegrins
US20070191292A1 (en) Antimycotic rhamnolipid compositions and related methods of use
US8043626B2 (en) Fatty acid antimicrobial
KR20060135006A (en) Zinc preservative composition and method of use
Blanco et al. Efficacy of a fixed combination of tetracycline, chloramphenicol, and colistimethate sodium for treatment of Candida albicans keratitis
US7288622B1 (en) Composition for treatment of burns and wounds
US20050260243A1 (en) Method of treating microbial plant diseases
US20170232064A1 (en) Formulations for histatin therapeutics
KR20220034832A (en) New treatment for protothecaosis
Quesnel et al. Synergism between chlorhexidine and sulphadiazine
KR0131288B1 (en) Aerosol spray composition for removing fungus using new fungicides
Furgiuele et al. Newer antibiotics: Their intraocular penetration
Schmatz et al. Antipneumocystis activity of water-soluble lipopeptide L-693,989 in rats
US20040024020A1 (en) Biocidal agents and methods of use
KNIGHT Human models for in vivo and in vitro assessment of topical antifungal compounds
US20190276505A1 (en) Antimicrobial peptides comprising epsilon lysine residues
KR102250981B1 (en) Antimicrobial peptide derivatives with improved antimicrobial activity, hemolytic stability and serum stability
IE54553B1 (en) Antifungal compositions
JP4157988B2 (en) Water-soluble preparations with no contraindications
CN111228462A (en) Antimicrobial peptide preparation and preparation method thereof
US10633420B2 (en) Antimicrobial peptides with wound healing activity
JPH07252105A (en) Liquid disinfectant
CA3103390A1 (en) Enhancement of antibacterial actions of a depsipeptide antibiotic using synergistic amounts of boric acid

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20091007

Year of fee payment: 13

LAPS Lapse due to unpaid annual fee